EMJ GOLD: Pharma news, views and analysis

In the penultimate episode of Season 4, the GOLD team are joined by Dr Zsuzsanna Devecseri, Vice President and Head of Global Oncology Medical, Sanofi Genzyme, to discuss her career journey and experience within the pharmaceutical industry. Isabel and Zsuzsanna explore a wide range of topics during their conversation, including diversity and inclusion, the importance of climbing the ranks of leadership at the right pace, ensuring personalised medicines can reach patients in need and much more. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Elevating pharma's parental leave policies: https://www.emg-gold.com/post/elevating-pharma-s-parental-leave-policies Setting the stage for a more equitable future: https://www.emg-gold.com/post/setting-the-stage-for-a-more-equitable-future Driving access to all medicines: https://www.emg-gold.com/post/driving-access-to-all-medicines Diversity: from ideas to action: https://www.emg-gold.com/post/diversity-from-ideas-to-action

This week on the GOLD Podcast, Isabel and Jade present a conversation with Gaurav Sanganee, Managing Director and Principal Consultant, Closing Delta, about how pharmaceutical teams can make the most of a tight budget and leverage digital transformation for the benefit of customers and patients. During their discussion, Jade and Gaurav delve into his transition from retail to pharma, explore how companies can make quick wins by leveraging modular content and omnichannel and how AI is facilitating the digital transformation of marketing strategies. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Upgrading the personal touch in CX https://www.emg-gold.com/post/upgrading-the-personal-touch-in-cx AI, ChatGPT and modernising medical affairs https://www.emg-gold.com/post/ai-chatgpt-and-modernising-medical-affairs Super reps, ChatGPT and pharma's future on social media https://www.emg-gold.com/post/podcast-super-reps-chatgpt-and-pharma-s-future-on-social-media

This week on the GOLD podcast, Isabel is joined by Matt Lewis, Co-Founder of Inizio Medical Analytics and Innovation, to discuss the future of AI in the pharmaceutical industry and the potential uses of ChatGPT in medical affairs. In this episode, Matt explores the need to modernise medical affairs, top ways pharma teams could save time and resources with ChatGPT, the likelihood of AI one day becoming as commonplace as electricity and much more. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Is medical affairs the Ferrari of the pharma industry?: https://www.emg-gold.com/post/podcast-is-medical-affairs-the-ferrari-of-the-pharma-industry Medical affairs, AI and insight generation: https://www.emg-gold.com/post/medical-affairs-ai-and-insight-generation Super reps, ChatGPT and pharma's future on social media: https://www.emg-gold.com/post/podcast-super-reps-chatgpt-and-pharma-s-future-on-social-media Revealing the true value of medical affairs: https://www.emg-gold.com/post/revealing-the-true-value-of-medical-affairs

This week on the GOLD podcast, the team is joined by Claudia Martínez, Research Programme Manager, Generics and Diabetes Care, Access to Medicine Foundation, to discuss all things access within the pharmaceutical industry. In this episode, Claudia and Jade explore a range of topics, including the story behind her passion for access to medicine, the industry's progress in making medicines more widely available in low- and middle-income countries and the Foundation's latest focus on driving access to generic drugs. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Claudia's first GOLD Podcast: https://www.emg-gold.com/post/podcast-talking-to-claudia-martinez Pharma in Kenya: https://www.emg-gold.com/post/pharma-in-kenya Pharma in India: https://www.emg-gold.com/post/pharma-in-india

This week, the GOLD team is delighted to bring you a special International Women's Day (IWD) podcast featuring Pallavi Bansal, Associate Vice President of Oncology, Genitourinary Cancers and Haematology, Merck, and Emma Chaffin, Vice President, Country Head and Site Lead, Galapagos. The two women reflect on this year's IWD theme, #EmbracingEquity, why female representation in pharma is so important and how leaders can foster a sense of belonging within their organisations. Isabel and Jade also discuss the latest GOLD content on female representation and equality in pharma. Additional resources: If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Infographic: Attracting more diverse talent into STEM https://www.emg-gold.com/_files/ugd/b8a9db_153874fc1b484455a9d2840f3118317c.pdf Elevating pharma's parental leave policies: https://www.emg-gold.com/post/elevating-pharma-s-parental-leave-policies Reverse mentoring: a how-to guide: https://www.emg-gold.com/post/reverse-mentoring-a-how-to-guide Setting the stage for a more equitable future: https://www.emg-gold.com/post/setting-the-stage-for-a-more-equitable-future HBA Gender Parity Collaborative https://genderparity.hbanet.org/

This week, Isabel catches up with GOLD's long-time friend Bora Erdemli, Associate Principal and Leader of Medical Affairs Practice, Europe, ZS. She asks Bora to break down the value of the medical affairs function, asking whether it is being properly utilised by pharma organisations. Bora also shares his thoughts on the future of the MSL, what skills new recruits will need to succeed and his top predictions for the next five years in MA. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Revealing the true value of medical affairs https://www.emg-gold.com/post/revealing-the-true-value-of-medical-affairs Mastering medical affairs https://www.emg-gold.com/post/mastering-medical-affairs Darshan Kulkarni on Super reps, ChatGPT and pharma's future on social media https://www.emg-gold.com/post/podcast-super-reps-chatgpt-and-pharma-s-future-on-social-media

This week, GOLD talks to Darshan Kulkarni, Principal Attorney, The Kulkarni Law Firm, which focuses on regulatory and compliance for life sciences, about key trends in medical affairs and marketing today. He discusses whether MSLs will one day replace sales reps, the role of ChatGPT in healthcare, pharma's future on social media and much more. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: The feature Darshan contributed to: Confronting health inequities for transgender patients https://www.emg-gold.com/post/confronting-health-inequities-for-transgender-patients A takeover, a tweet and trouble for pharma marketers https://www.emg-gold.com/post/a-takeover-a-tweet-trouble-for-pharma-marketers Preparing MSLs for the spotlight https://www.emg-gold.com/post/preparing-msls-for-the-spotlight Davidek Herron on 5 ways pharma can ensure omnichannel success https://www.emg-gold.com/post/5-ways-pharma-can-ensure-omnichannel-success-davidek-herron Mental health matters in pharma's approach to care https://www.emg-gold.com/post/mental-health-matters-in-pharma-s-approach-to-care

This week, the team shares a teaser of GOLD's latest catalyst interview with Mina Makar, Senior Vice President, Global Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca. He talks to Isabel about why he decided to leave pharmacy for pharma, his passion for tackling unmet needs and championing the patient perspective as well as his thoughts on how to be an effective leader. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Catalyst interview: Mina Makar on tackling unmet patient needs https://www.emg-gold.com/post/mina-makar-on-tackling-unmet-patient-needs Turning patient insights into action https://www.emg-gold.com/post/turning-patient-insights-into-action Our last catalyst: John Wahba on the medical affairs evolution https://www.emg-gold.com/post/john-wahba-on-the-medical-affairs-evolution

The GOLD Podcast is back for Season 4, and it is returning with a bang as Helena speaks to Kavita Panke, Disease Area Strategy Leader, Neurodegeneration, Janssen. An inspiring pharma leader working in a rapidly evolving area of the industry, Kavita reveals the reasons behind her passion for neuroscience, how to build a high-performing team and her inspiring goals for 2023. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: The brains behind neurological breakthroughs The vast galaxy of neurology https://www.emg-gold.com/post/the-vast-galaxy-of-neurology The value of purpose https://www.emg-gold.com/post/the-value-of-purpose Claus Zieler on leadership https://www.emg-gold.com/post/claus-zieler-on-leadership

For our fourth and final GOLD Nugget of Season 3, Helena looks back to our Catalyst interview with Reshema Kemps-Polanco, Executive Vice President and US Head, Novartis Oncology, sharing some of Reshema's ideas for tackling clinical trial recruitment gaps, her personal take on Nelson Mandela's approach to dealing with failure and why she believes equal representation matters in the pharma industry and beyond. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Reshema's full episode: Meet GOLD's next catalyst – Reshema Kemps-Polanco https://www.emg-gold.com/post/podcast-meet-gold-s-next-catalyst-visionary-leader-reshema-kemps-polanco Catalyst interview: Reshema Kemps-Polanco on drive, diversity and finding time for family https://www.emg-gold.com/post/reshema-kemps-polanco-on-drive-diversity-and-finding-time-for-family Ripples of change in R&D https://www.emg-gold.com/post/ripples-of-change-in-research-and-development Setting the stage for a more equitable future https://www.emg-gold.com/post/setting-the-stage-for-a-more-equitable-future